Openhouse Procedure - Div. Active Ingredients Tender - 77339795

Procurement Summary

Country: Germany

Summary: Openhouse Procedure - Div. Active Ingredients from October 1St, 2022

Deadline: 05 Sep 2024

Posting Date: 14 Jan 2023

Other Information

Notice Type: Tender

TOT Ref.No.: 77339795

Document Ref. No.: 024127-2023

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Conclusion of non-exclusive discount agreements according to § 130 a paragraph 8 SGB V with the possibility of conclusion at any time as part of the so-called "Open House procedure" for various active pharmaceutical ingredients with the earliest possible start of the contract on October 1st, 2022.
.
The specific active pharmaceutical ingredients and the respective VeContract starts can be found in the current list of active pharmaceutical ingredients in the project room of the procurement portal dtvp in the "Award documents" section.
.
As of October 1st, 2022, contracts for the following active ingredients will be offered:
.
Abacavir / lamivudine / zidovudine
Acetylcystein_non-RX non-RX
Acetylcystein_RX RX
Acetylsalicylic acid products that can only be prescribed according to Annex 1 AM-RL G-BA
Acitretin
Adefovir dipivoxil
Alitretinoin
Amifampridine
Anagrelide except N3 packs of the DAR HKP with 0.5 mg strength
Aripiprazole excluding DAR tablets/melt tablets and oral solutions
Atorvastatin/ezetimibe
beclometasone/formoterol
beclometasone/formoterol/glycopyrronium
bimatoprost
biperiden
bortezomib
brivudine
budesonide except inhalatives
calcipotriol
calcium / colecalciferol
ceftriaxone
clomipramine 75 mg strength, slow-release
clostridium botulinum except lifestyle drugs
colecalciferol non-RX
colecalciferol RX
colistin
cyproterone
deferasirox
desloratadin
desogestrel / ethinylestradiol
dienogest
dienogest / ethinylestradiol
diltiazem
distigmin
dornase alpha
dronedarone
drospirenone / ethinylestradiol
ebastine
iron II oral DAR/exclusively according to Appendix 1 AM-RL G-BA prescribe...
Document Type : Corrigendum/Additional information (Please refer tender document)

Reference Number : 2022-06 Abteilung Arzeimittel

Contract Type : Supplies

33600000 - Pharmaceutical products

Authority Type : Body governed by public law

Type of Procedure : Open procedure

Regulation : European Union, with participation by GPA countries

Bid Type : Submission for all lots

Doc Title : Pharmaceutical products

Dispatch Date : 2023-01-09

Publish Date : 2023-01-13

Submission Date : 2024-09-05

Documents

 Tender Notice